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Summary.-The effect has been examined of various host treatments (C. parvum
injection, immunization, thoracic irradiation, cyclophosphamide injection, and
anticoagulation) on both lung colonyformation and clearance ofradioactive cellsfrom
the lungs after i.v. injection of tumour cells. Two tumour-host models have been
used: the non-immunogenic KHT tumour in C3H/Km mice, and the immunogenic
EMT6 tumour in BALB/c/Ka mice. Even for the at most weakly immunogenic KHT
tumour, the number of artificial pulmonary metastases could be modified by a factor
of up to 104 by different host treatments before i.v. inoculation of tumour cells.
For all pretreatments except immunization, the shape of the curve of loss of radio-
activity from the lungs vs time was biphasic, with an initial steep portion represent-
ing intravascular death of the tumour cells, followed 1-2 days after tumour-cell
injection by a shallow exponential curve. It was concluded that the shallow slope
represented spontaneous death of tumour cells in the perivascular tissues.
Essentially all the injected tumour cells lodged initially in the lungs, and this was
unaffected by the different host treatments. Furthermore, except for specific immu-
nization, cell death in the perivascular tissues was also unaffected by host treatment.
However, the survival of the tumour cells during the 24 h after injection (before they
became extravascular) was extremely dependent on the particular host pretreatment.
It would appear from these studies that host treatments such as C. parvum injection
or anticoagulation can markedly affect the number of blood-borne pulmonary meta-
stases, but they will only be effective if given before the tumour cells arrive in the lung
vasculature.
A VARIETY ofhost treatments have been
found markedly to affect the incidence of
spontaneous blood-borne metastases, and
the number of artificial pulmonary
"metastases" arising from an i.v. inocula-
tion of tumour cells. These factors include
anticoagulation (Agostino & Clifton,
1962; Brown, 1973a; Hilgard & Thornes,
1976), corticosteroids (De Brabander et al.,
1974), pulmonary irradiation (Brown,
1973b; Fidler & Zeidman, 1972; Withers &
Milas, 1973), cyclophosphamide (Carmel &
Brown, 1977; Steel & Adams, 1977; van
Putten et al., 1975), specific immunization
(Fidler et al., 1977; Proctor et al., 1976;
Wexler et al., 1975) and nonspecific
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stimulation of the reticuloendothelial sys-
tem with agents such as C. parvum
(Bomford & Olivotto, 1974; Sadler &
Castro, 1976).
In order to quantitate these effects,
many of the above workers have used
lung-colony counting after the i.v. injec-
tion of a known number of tumour cells,
and have invariably found that only a
small minority (often <0.1%) of the
tumour cells injected into the bloodstream
ever form a metastasis, implying that the
majority of the injected cells die or be-
come permanently dormant. To determine
which of these occurs, and with what
kinetics, various investigators haveJ. M. BROWN AND E. T. PARKER
labelled the tumour cells before inocula-
tion with a radioactive marker assumed to
stay with the cells until they die. The most
commonly used ones have been 51Cr
(Withers & Milas, 1973; Bomford &
Olivotto, 1974; Fisher & Fisher, 1967;
Hilgard et al., 1972) and 1251-labelled
iododeoxyuridine (Brown, 1973a, b;
Fidler, 1970; Hofer et al., 1969; Peters et
al., 1978; Proctor et al., 1976; Glaves &
Weiss, 1976). However, it has been shown
that these 2 isotopes give different
results, and that the distribution of 51Cr
label is not correlated with the distribu-
tion of injected live tumour cells, because
of extensive reutilization of 5lCr-labelled
material (Brown, 1973a; Hofer et al.,
1969). Since IUdR is very weakly re-
utilized, it isthetumour-celllabelofchoice.
In those studies using 125IUdR-labelled
cells in which the radioactivity in the
lungs of mice has been followed for more
than 1 day after tumour-cell injection,
a biphasic curve with an initial rapid loss
of radioactivity within the first 1-2 days,
followed by a gradual exponential loss
over subsequent days, has been found
(Brown, 1973a, b; Liotta & DeLisi, 1977;
Liotta et al., 1978; De Ruiter et al., 1976).
It has recently been proposed that the
initial rapid loss of radioactivity in the
first 1-2 days after injection is due to
intravascular death of tumour cells
trapped in the lungs, and the slower death
rate more than 2 days after injection is
due to cell death in the extravascular
tissues (Liotta & DeLisi, 1977).
The present study was in order to
determine in what way a variety ofagents
which affect the yield of artificial pul-
monary metastases would also affect the
curve for loss ofradioactively labelled cells
from the lungs. Two tumour systems were
chosen (one immunogenic and one non-
immunogenic) and host treatments in-
cluded specific immunization, cyclophos-
phamide and C. parvum pre-treatments of
the animals. In addition, data from pre-
vious studies with warfarin anticoagula-
tion and pulmonary irradiation were
analysed in the same manner.
MATERIALS AND METHODS
The mice used in these studies were the
inbred strains, C3H/Km and BALB/c/Ka.
Themicewere bredandhousedunderspecific-
pathogen-free conditions up to their intro-
duction into experiments at the age of 3-4
months. The tumours used were the KHT
sarcoma, syngeneic to C3H/Km mice, and
the EMT6 tumour, syngeneic to BALB/c/Ka
mice. The KHT sarcoma arose spontaneously
at the base ofthe ear ofa C3H/Km mouse in
1962, and has since then been maintained by
serial s.c. passage into syngeneic mice. The
other tumour used, the EMT6 tumour, was
obtained by clonal selection from a mammary
tumour, the KHJJ carcinoma, which origina-
ted from thetransplantation ofa hyperplastic
alveolar nodule into the mammary fat pad.
This tumour has been maintained by alter-
nate passage into BALB/c/Ka mice and in
vitro. A full description ofthe derivation and
handling procedures ofthe EMT6 tumour has
been published previously (Rockwell et al.,
1972).
Details of the preparation of cell suspen-
sions of the KHT tumour, the lung-colony
assay and radioactive labelling of these cells
have been published previously (Brown,
1973a). In outline, the tumour was made into
a single-cell suspension by mincing and by
gentle treatment with 0.05% trypsin solution
for 15 min. A haemacytometer count of
trypan-blue-excluding cells enabled a given
number oftumour cells to be injected i.v. into
syngeneic C3H mice. Suspensions of radio-
active KHT cells were prepared by giving
4 i.p. injections (8 h apart) of 125IUdR
(Schwartz/Mann, Orangeburg, N.Y., sp. act.
50-100 Ci/mmol) at a dose of 0 5 uCi/g body
wt per injection, and 1 h after the 4th injec-
tion the mice were killed and a tumour cell
suspension prepared as described above,
except that the cells received 4 washings to
remove any unbound radioactivity. Six mice
per experimental point were used in all
experiments.
To assayfor lung colonies, micewereinject-
ed with a known number of KHT tumour
cells in a volume of 0-2 ml Hanks' solution,
killed 17-18 days later, and their lungs fixed
without inflation in Bouin's solution (for
24 h) and then in 95% alcohol. Surface col-
onies were counted with the aid of a dissect-
ing microscope. Histological examination
revealed that all nodules were tumours and
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that 60-70% of the total number of pul-
monary tumours were counted using this
technique. In all experiments in which the
surface lung colonies were counted, 12 mice
perpoint wereused.
For the EMT6 tumour, the only modifica-
tion on the previously published description
(Rockwell et al., 1972) is that the tumour line
used has been adapted for efficient growth in
the lungs by alternating passage in vivo (by
i.v. inoculation into BALB/c mice) and in
vitro. It is thus designated the EMT6/St/lu
line. All details of the lung colony assay and
radioactive counting of the EMT6 cells are
as described above, with the exception that
the EMT6 cells were labelled with '25IUdR
in vitro. EMT6 cells in exponential growth
were given growth medium containing
'25IUdR at a concentration of 0-2 ,uCi/ml.
After 24 h, the medium was removed, the
cells harvested by trypsinization and washed
x 4 before injection into recipient BALB/c
mice. As with the KHT cells, the lungs ofthe
mice were removed at various times after
injection, fixed in acetic alcohol, given 2
changes of70% alcohol (to remove any acid-
soluble fraction) and the organs were counted
in a gamma counter (Beckman, Biogamma
II).
Corynebacterium parvum was obtained
from Burroughs Wellcome, Research Triangle
Park, N.C., as a suspension of washed,
formalin-killed organisms in physiological
pyrogen-free 0-9% NaCl solution. The original
solution was diluted 1: 4 with physiological
saline to give an injection volume per mouse
of 0-2 ml containing 0 35 mg dry weight of
C.parvum.
RESULTS
Effect of C. parvum and other host treat-
ments on the incidence of lung colonies
Figs. 1 and 2 show the results of
experiments to find out the period over
which a single i.v. injection of 0'35 mg/
mouse of C. parvum was effective in
reducing the number of lung colonies
arising from an i.v. injection of KHT or
EMT6 tumour cells. It can be seen that
the results obtained from the 2 tumour
lines are quite similar: C. parvum injection
produces a 100-fold reduction in the num-
ber of lung colonies when given 4 days
before tumour-cell injection. Also the
effect is relatively long-lasting, with a
10-fold reduction in the number of lung
colonies remaining with an interval of
2-3 weeks between the C. parvum and the
tumour-cell injections.
The maximum reduction in the number
of lung colonies was not critically de-
pendent on the C. parvum dose: a similar
100-fold reduction in the number of lung
colonies was found when doses of 1-4 mg-
0-1 mg/mouse of C. parvum were injected
4 days before injection of KHT cells.
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FIG. 1.-The number of lung colonies per
mouse in mice injected with 3 x 105 KHT
tumour cells on Day 0. The mice were also
injected i.p. with 0-35 mg C. parvum (@)
or saline (0) at various times before (-)
or after (+) the tumour cells. Each point
shows the mean + s.e. from 12 C3H
mice.
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FIG. 2. The number of lung colonies per
mouse in mice injected with 3 x 103 EMT6
tumour cells on Day 0. The mice were also
injected i.p. with 0-35 mg C. parvum (0)
or saline (0) at various times before (-)
or after the tumour cells. Each point
shows the mean + s.e. from 12 BALB/c
mice.
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FIG. 3.-The mean diameter of lung colonies
as a function of time after injection of
EMT6 tumour cells into saline (A) or C.
parvum (X) (0-35 mg/mouse 4 days before
cell injection) pretreated BALB/c mice.
About 100-fold more cells were injected in
the C. parvum group so that the absolute
number of colonies equalled that of the
controls. An average of20 colonies per point
from 4 separate mice were used to derive
the mean diameter.
Fig. 3 shows data on the size of colonies
from C. parvum-treated mice, compared
to those from control mice in the same
experiment. Although there were 100-
foldfewer EMT6 coloniesinthe C.parvum-
treated mice, the average size of the
colonies was not different between the two
groups.
There have been various other treat-
ments of the host before i.v. inoculation
of the tumour cells, the results of some
having been published previously (Brown,
1973a, b; Carmel & Brown, 1977). For
completeness Table I shows the results of
various experiments with the KHT and
EMT6 tumours over a period of 4 years in
which these host treatments were given.
Besides the previously discussed C.
parvum data, these results indicate that:
1. The KHT sarcoma is non-immuno-
genic or only weakly immunogenic com-
pared to the strongly immunogenic EMT6
tumour.
2. Prior treatment of recipient mice
with cyclophosphamide can increase the
number of lung colonies arising from a
TABLE I.-Effect of host treatments on artificial lung "metastases" (No./mouse +s.e.,
12 mice)
Host treatment
Cyclo-
Immun- phospha-
izedt midett
Anti-
coagula-
LTIt tion**
Tumour-
bearing
19-1 + 3-4
- I/U-t-i' - -1-
23-6 + 1-7
11*4 + 3*0
- 138-0+ 14-4
0
110+ 14
25-5+56 -
* 0-35 mg/mouse i.v. 4 days before tumour-cell injection.
t Immunized with 3 i.p. injections ofheavily irradiated tumour cells 21, 14 and 7 days before tumour-cell
injection.
tt 200 mg/kg i.p. 24 h before tumour-cell injection (Carmel & Brown, 1977).
$ Local thoracic irradiation (2000 rad) 48 h before tumour-cell injection (Brown & Marsa, 1978).
** Warfarin in drinking water for 4 days before and 3 days after tumour-cell injection. The concentration
of sodium warfarin (Coumadin, Endo Laboratories Inc., Garden City, N.Y.) in the drinking water was
adjusted to maintain the prothrombin times at 2-4 x normal by alternating every 2 days between 7-5 mg/l
and 5.0 mg/l (Brown, 1973a).
I
Li
54
+C,
z
0
CD'
0
z
I.
0
0
cc UJ
Tumour
cells
KHT sarcoma
EMT6 tumour
No.
injected
3x 105
2 x 105
6 x 103
2 x 104
105
3x 105
5X 103
5 X 103
103
5x 104
Saline
injected
91-6 + 7-4
31*3 + 4-4
2-4+ 1-6
1-6 + 0-3
63-7 + 9 0
157-3+ 11-8
62-3 + 4-2
147 + 19
12-3+ 1-8
78-6± 12-6
C.
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0-6+0*6
0-9+0-2
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given injection of tumour cells by a factor
of 10-100.
3. Local thoracic irradiation enhances
the number of lung colonies by a factor of
up to 20 for the KHT sarcoma.
4. Warfarin anticoagulation can reduce
the number of lung colonies by a factor
of 3-6.
5. The presence of a growing primary
KHT tumour does not affect the number
of lung colonies arising from an i.v.
inoculum ofKHT cells.
Thus it is apparent that the above range
ofhosttreatmentspreceding acellinoculum
can alter the cloning efficiency (number of
lung colonies/no. cells injected) by a factor
of , 104, even for the non-immunogenic
KHT tumour. It was in order to see how
these changes would affect the kinetics of
cell removal from the lungs that the
labelled-cell studies were performed.
Studies with labelled KHT cells
As an initial check of the relationship
between lung radioactivity and the pre-
sence ofintact tumour cells, an experiment
was performed in which a suspension of
labelled KHT cells was divided into 4
groups. The first group of cells was
sterilized by radiation (10,000 rad) the
second was heat-killed (56°C for 1 h) and
the third was killed by fixation in for-
malin, the fourth group remaining as a
control. Each group was then washed to
remove unbound radioactivity and 2 x 106
labelled cells from each of the 4 groups
were injected into recipient C3H mice, and
the lungs counted at intervals. Table II
shows the results. It is apparent that at
1-2 days after injection no significant
radioactivity can be detected in any ofthe
groups in which the cells were killed before
injection. This demonstrates that labelled
products released from dying cells are not
retained in the lungs, i.e. reutilization of
label is negligible. Thus the radioactive
count is proportional to the number of
intact (presumably viable) tumour cells
at times beyond 1 day after iujection.
A similar result was not obtained with
51Cr-labelled tumour cells in this case
there was little or no difference in the
retention of radioactivity by the lungs
from animals injected with live or
radiation-sterilized cells (data not shown).
Fig. 4 shows the results of 2 experiments
in which the loss of radioactivity from the
lungs of C13H mice was examined in mice
injected with saline, cyclophosphamide or
C. parvurn before injection of 2 x 106
125IUdR-labelled KHT cells. Best-fitting
least-squares regression lines have been
fitted to all the data from 1 day after
injection. These results showed the
following:
1. There was no significant difference
between the radioactivity in the lungs
5 min after injection of any of the groups:
essentially all (80% + ) of the activity was
initially trapped in the lungs.
2. No group had a final slope ofthe best-
fitting line for data beyond 1 day after
injection which was significantly different
from that of any other group. In other
words, the death or loss of cells later than
1 day after injection was the same in the
TABLE II. Percent radioactivity remaining in lungs at different times after injection of
live or dead 125IUdR-labelled KHT cells*
% Radioactiv-ity at different times**
Treatmenit 10 min 6 li 24 hi 2 (lay 4 (lay
Control (live cells) 60) + 3 26 + 2 14 + 3 9-6 + 1-4 5-0 + 1-2
Radiation-killed 64 + 4 12 + 3 0-2 +0-1 BGDt <BGD
Heat-killed 19+1 0-3+0.2 0-2+0-1 <BGD <BGD
Formalin-killed 28+ 8 0-6+ 01 <BGD <BGD <BGD
* All mice inijected with 200 mg/kg cyclop)hospllamide i.p. 24 lI beforie tumour-cell injection to maximize
turmour-cell survival.
t Backgroutndl level = 0-05%.
Eachi v7-aluc is t}le meail +s.e. fioro 6i (lifferciit mice.
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FIG. 4.-The percent remaining radioactivity
of the lungs of mice injected with saline,
cyclophosphamide (200 mg/kg, Day 1) or
C. parvum (0.35 mg/mouse, Day 4) at dif-
ferent times after an i.v. injectionr of 2 x 106
125IUdR-labelled KHT cells. Th e straight
lines are best-fitting least-squaries regres-
sion lines to the data from 1 to 14 days. The
differentsymbols (circles, triangle3,squares)
represent data obtained in different experi-
ments. Each point shows the mean + s.e.
from 6 mice.
3 groups irrespective of the initial treat-
ment.
3. All of the difference bet1ween the 3
groups occurred between 0 an 24 h after
injection, and was manifested by a much
steeper loss of radioactivity in the C.
parvum group than in the saline group,
and a less pronounced drop in the cyclo-
phosphamide group than in the control
group.
We have published previously similar
experiments with KHT cells, in which the
recipient animals were either anticoagu-
lated before injection (Brown, 1973a) or
received local thoracic irradiation before
injection (Brown, 1973b). Since these
experiments gave essentially similar re-
sults (no change in the initial trapping of
cells, no difference in the final slope and a
TABLE III.-Initial trapping and half-time
for loss ofradioactivityfrom lungs in mice
treated in difJerent ways (mean +s.e.
from 6 mice)
Exp.
No. Treatment
1 Control
1000 rad to thorax
2 Control
Warfarin pretreatment
3* Control
Cyclophosphamide
4 Control
C.parvum
Trapped
initially
in lungs
(5 min
after
injection)
101+7
98+5
99 + 14
110+ 3
67+5
60+ 3
87+3
83+2
TI/2 of
slope
from 1
or 2 days
to Day
14 (days)
2-3+0-3
2-5+0-1
2-5+ 0-2
2-7+0-2
2-3+0-3t
2-6+ 0-3
2-3+0-3t
2-0+0-4
* The relatively low initial trapping seen in this
experiment was probably due to inadequate removal
ofunboundradioactivity.
t Calculated from pooled data from 3 consecutive
experiments (data shown inFig. 4).
difference in the period 0 to 24 h after
injection) we have included the data for
the initial trapping and the final slopes
from these experiments with a summary of
the ones presented here (Table III).
It is apparent from this summary ofthe
results obtained from different experi-
ments on the clearance of KHT cells from
the lungs and that for the eventual num-
ber of lung colonies formed (Table I) that
neither the percentage of cells initially
trapped in the lung nor the slope of the
terminal portion of the radioactive-loss
curve are affected by host treatments
which modify the number of lung colonies
by a factor of up to 104.
Studies with labelled EMT6 cells
Fig. 5 shows the results of an experi-
ment in which mice were pretreated either
with saline, cyclophosphamide or C.
parvumbeforeinjectionof2 x 106 125IUdR-
labelled EMT6 cells. Again, it was found
that the initial number of cells trapped
was close to 100% in all instances, and
that the slopes of the lines fitted from 2
days onwards were not significantly
different from each other. Thus, as before,
cyclophosphamide and C. parvum pre-
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FiG. 5.- The percent remaining radioactivity
of the lungs of mice injected witlh saline,
cyclophosphamide (200 mg/kg, Day 1) or
C. parvum (0 35 mg/mouse, Day 4) at dif-
ferent times after an i.v. injection of 2 x 106
125IUdR-labelled EMT6 cells. The straight
lines are best-fittinig least-squares regres-
sion lines to the dlata from 2 to 13 days. 6
mice per point.
treatment of animals affected neither the
initial trapping of cells in the lungs nor
the subsequent loss of cells beyond 1-2
days after injection, but made a large
difference to the retention of intact cells in
the lungs within the 1-2 days after
injection.
A similar experiment was performed
with the EMT6 cells injected either into
normal hosts or hosts which had been pre-
immunized by 3 injections of 107 heavily
irradiated cells at 2-week intervals. These
data (Fig. 6) showed an entirely different
picture. Although there was no difference
in the initial trapping of cells in the lungs,
in this case there was little or no difference
in the retention of intact tumour cells in
the lungs in the first 1 to 2 days after
injection, but a marked difference in the
subsequent slope of the line drawn from
2 days after the injection of radioactive
cells.
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FIG. 6. Thle percent remaining radioactixvity
in the lungs of mice either pretreated with
saline or given 3 immunizing injections I
week apart of 107 radiation-sterilized EMIT6
cells, as a function of time after an i.
injection of 5 x 106 125IUdR-labellecl
EMT6 cells. 6 mice per point.
DISCUSSION
Two principal conclusions can be drawn
from the data from these experiments.
Firstly, pre-treatment of the host with
agents which alter the clonogenicity of
both the non-immunogenic KHT and the
immunogenic EMT6 tumour over a range
of 10,000, makes little or no difference to
the initial number of cells trapped in the
lungs: in all cases, close to 1000% of the
cells are initially trapped in the lungs
after a single i.v. injection of the tumour
cells. Secondly, except for specific im-
munization, all the host treatments
which affected the incidence of lung
colonies produced no differences in the
final slopes of the radioactive-loss curve:
almost all the differences between the
different treatments occurred in the period
5 min to 24 h after tumour-cell injection.
The first conclusion--that host treat-
ments do not affect the initial arrest of
tumour cells in the lungs-was also
reached by Fidler et al. (1977) for the case
of various immunological modifications of
the tumour-host status, by Peters et al.
(1978) for local thoracic irradiation and
previously by ourselves for anticoagulation
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and lung irradiation (Brown, 1973a, b).
This conclusion, however, is at variance
with the work of WVeiss and co-workers
(Weiss et al., 1974; Glaves & Weiss, 1976)
who have concluded that immunological
modifications of the host against the
tumour affects the initial pattern of arrest
after i.v. injection of tumour cells. Their
conclusions, however, are all based on the
radioactive count I h after injection and,
from the present data and that of others
(Fidler et al., 1977) by 1 h significant loss
ofradioactivity from the lungs has already
occurred. Thus it is possible that the
differences measured by Weiss and col-
leagues reflect differences in the killing of
trapped cells rather than differences in the
initial arrest.
The rapid loss of radioactivity in the
first few hours after cell injection has been
observed by all workers in the field. This
loss ofradioactivity could be due either to
death oftumour cells within the lungs (and
subsequent elimination of radioactive cell
debris) or to the passage of intact tumour
cells from the pulmonary vessels into the
heart, to be distributed systemically.
We investigated the latter possibility by
injecting EMT6 tumour cells directly into
the left heart of mice which were either
untreated or had been treated with
cyclophosphamide l day before injection.
The results (Table IV) demonstrate that,
in mice killed 17 days after injection, no
colonies are found in organs other than
the lungs if the injection is i.v., but
colonies can be seen in the liver and kid-
neys after injection of 10-fold fewer live
tumour cells via the iiitracardiac route.
This demonstrates that little if any of the
initial loss of radioactivity from the lungs
could be due to the reseeding of live cells
elsewhere in the body. The same con-
clusion was reached both by Proctor et al.
(1976) and by Peters et al. (1978) using
different bioassay procedures for the
blood collected from the abdominal aorta.
Thus it seems reasonable to conclude that
essentially all ( > 90°u) of the loss of
radioactivity from the lungs in the first
24 h after cell injection is due to death of
tumour cells trapped in the lungs, and not
to reseeding of viable cells elsewhere.
If death of the trapped tumour cells
occurs in the lungs, the question arises as
to the precise anatomical location of this
death. It is now generally accepted that
for the majority of tumours the trapped
cells must migrate through the walls ofthe
blood vessels into the perivascular tissues
before they can start to proliferate and
become metastases. This conclusion de-
rives primarily from the elegant micro-
cinematographic studies of tumour cells
in the rabbit ear chamber by Wood
and colleagues (Johnson & Wood, 1963;
Wood, 1964, 1971) and from several light-
and electron-microscopic studies (Chew
& Wallace, 1976; Jones et al., 1971;
Ludatscher et al., 1967; Sindelar et al.,
1975). These morphological studies have
shown that the migration of tumour cells
out ofthe blood vessels can occur between
22 h and 3 days after attachment (Wood,
TABLE IV. Distribution of colonies in different organs in mice injected with EMT6 cells
via the i.v. or intracardiac route
No. of
Route of cells
injection injected
I.v. 1(3
103
Intra- 102
cardiac 102
103
103
Pre-
treatment
of mice
Saline
CP*
Saline
CP
Saline
CP
Mean number of colonies per mouse
(±s.e.)
Lungs Liver Kidneys Spleen
12-3+ 1-8 0 0 0
110+ 14 0 0 0
0 02+02 0-2+0-2 0
4 0+3-0 1-0 2-0 0
1-7+ 1-2 5 0+0 9 5-7+2-2 0
15-3 + 2-9 8-0 + 1-2 23-3 + 5-4 2-0 + 0-6
* CP=cyclophospliamide (200 mg/kg) injected i.p. 24 h before tumour-cell injection.
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1964, 1971; Sindelar et al., 1975). How-
ever, probably the most extensive of the
morphological studies are those performed
by Wallace and colleagues (Jones et al.,
1971; Chew & Wallace, 1976) and these
authors, working with the Walker 256
tumour in Sprague-Dawley rats, con-
cluded that those tumour cells which leave
the pulmonary vasculature do so between
12 and 36 h after attachment. They also
concluded that most tumour cells seem to
perish intravascularly.
Thus the time scale of attainment of an
extravascular position for tumour cells
attached to the endothelial wall is similar
to that for the initial steep loss of radio-
activity from the lungs (i.e. the first 24 h
after i.v. injection). We have, both by
light and electron microscopy, obtained
preliminary confirmation with the KHT
tumour system of the same morphological
events and timing as described; we can
detect large platelet-rich thrombi in blood
vessels adjacent to tumour cells, and also
the attainment of an extravascular posi-
tion oftumour cells within 6 h ofinjection.
We also found, as reported by Chew &
Wallace (1976) that the platelet fibrin
thrombi are unstable and last only a few
hours. Thus the tumour cell has to get out
of the bloodstream before its surrounding
thrombus (which presumably offers some
form of protection) breaks down and
makes it even more liable to die. However,
the present data do not allow us to draw
any conclusions about the nature of the
intravascular death of tumour cells, or
even whether it is an active or a passive
process.
A further question arising from the
present data concerns the nature of the
final (shallow) slope of the radioactive
clearance curve beyond 1-2 days after
injection. Several possibilities exist.
1. Continued intravascular death of cells
remaining in the bloodstream
This would not appear to be a reason-
able explanation, not only because the
rate of cell killing is so much lower (thus
one would have to postulate a resistant
subpopulation) but because none of the
host treatments which markedly affect the
killing within the first 24 h make any
difference to this rate of cell loss or killing.
2. Leakage of radioactive label
Commerford (1965) has shown that in-
corporated 125IUdR is extremely stable,
free 1251 being released from DNA which
had incorporated 125IUdR only after cell
death. Thus this does not appear to be a
reasonable possibility.
3. Killing of cells by their incorporated
radioactivity
It is possible that the exponential loss of
radioactivity from 1 to 2 days could be
due to cytotoxicity produced by the in-
corporated radioactivity. This possibility
was checked by determining the number
of colonies produced by i.v. injection of
104 live and 5 x 106 heavily irradiated
KHT cells, the cells being either radio-
actively labelled or unlabelled.
The mean number of colonies in the 2
groups was 102+ 11 and 112+8 for the
radioactive and non-radioactive cell in-
jections respectively. Thus there was little
or no cytotoxicity of the label, as judged
by this assay.
4. Immunoloyical attack
Although it can be seen from Fig. 6 that
the immune response can increase sig-
nificantly the slope of the exponential
portion of the radioactive loss curve, it is
unlikely that the slope of the line in the
absence of prior immunization is due to
killing of tumour cells by this specific
immune response. The two reasons for this
are firstly that the loss starts within 2 days
of injection, which is too soon for an
immune response to have developed, and
secoiidly because the loss occurs not only
with the immunogenic EMT6 tumour but
also with the non-immunogenic KHT
tumour.
5. Cell death due to lack of nutrients
Since loss of radioactivity begins I to 2
days after injection, when the micro-
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metastases could onily be a few cells in
size, and therefore too small to possess
regions inadequately supplied with
nutrients, it is highly unlikely that this
could be responsible for cell death within
the tumours.
Since none of the above mechanisms
satisfactorily explains the exponential loss
of radioactivity 1-2 days after injection,
we must conclude that the loss of radio-
activity from these micrometastases is
due either to a spontaneous death rate of
the tumour cells (apoptosis) or to the
existence within the host of cells with a
natural cytotoxicity which is unaffected
by the host treatments studied. From a
further series of experiments in which we
have examined loss of radioactivity from
solid tumours and from EMT6 cells in
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O, Peri-vascular deatlh of tumouir cells.
, Intravascular dleatli ofattached tumour
cells.
x, Essentially all tumour (cells initially
trapped, not affected by lhost treatment,
and no reseedling of live cells.
vitro, we have concluded that the former
possibility is most likely to be correct: i.e.
there appears to be a spontaneous, pro-
liferation-dependent death rate of the
tumour cells, and this is responsible for
the progressive loss of radioactivity
(Brown et al., in preparation).
Fig. 7 is a schematic representation of
the radioactive loss curve for different
host treatments before cell injection. The
conclusions listed on this diagram are
reached in the present investigation, but
they are also consistent with conclusions
reached by other authors. For example,
Steel & Adams (1977) who found a large
increase in lung colonies when the mice
had been pre-treated with cyclophos-
phamide, also pointed out that there was
no difference in the size distribution of
colonies in treated and untreated re-
cipients. The data for C. parvum pretreat-
ment (Fig. 3) as well as (unpublished)
observations with cYclophosphamide,
thoracic irradiation and anticoagulation
of animals before cell injection, are in
agreement with this. However, with
specific immunization of the host before
cell inoculum, in those experiments in
which occasional EMT6 lung colonies
were seen, the size ofthe colonies was very
much less than in untreated recipients. It
would thus appear that the size distribu-
tion of colonies indicates whether the
slope of the radioactive-loss curve more
than 1-2 days after injection is the same
or different from controls.
It can be seen from a comparison of the
effect of host treatments on the number
ofmetastases (Table I) andthe correspond-
ing effects on the radioactive-loss curves
(Figs. 4 and 5) that the factors by which
these host treatments affect the incidence
of metastases are greater than those for
the radioactive-loss curves. For example,
the difference between the cloning effici-
ency for the KHT sarcoma in mice pre-
treated either with C. parvum or with
cyclophosphamide is approximately a
factor of 104, whereas the difference in cell
killing in the first 24 h observed from the
radioactive-loss curve (Fig. 4) is only a
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factor of 1]00. The explanation for this
discrepancy rests on the fact that different
numbers of cells were injected for each of
the end-points: for the radioactive-loss
curves, 2 x 06 radioactive cells were
injected, whereas to obtain lung colonies
fewer cells by a factor of 10 to 500 are
used. As we have noted for the KHT
tumour (Brown & Marsa (1978) and Peters
et al. (1978) have documented extensively)
both the cloning efficiency and the radio-
activity remaining in the lungs at 24 h
decline markedly when fewer cells are in-
jected. Thus, if the cell retention after
injecting large numbers of cells is between
1 and 10% after 24 h, it is clearly im-
possible for cyclophosphamide to increase
this by a factor of 100. Such a factor,
however, can and does occur when the cell
number and the cloning efficiency are
lower. Conversely, it also appears, as has
been previously pointed out with anti-
coagulation (Brown, 1973a) that the effect
of a host treatment which reduced lung
colonies is less when large numbers of cells
(106-5 x 106) are given. In fact the effect
of anticoagulation on the initial cell death
and on the eventual numbers of colonies is
identical wlhen the same number of cells is
given in each case (Brown, 1973a).
Finally, an important implication can
be drawn from the radioactive clearance
curve for C. parvum-treated mice. Al-
though it is clear from Figs 1 and 2 that
C. parvurn is active over a long period, it is
clear from the radioactive-loss curves for
both the KHT and EMT6 tumours that
C. parvurn has no effect on tumour cells
once they have left the vascular lumen. It
is also seen in Figs 1 and 2 that there is
little or no influence of C. parvurm given
1-2 days after cell inoculation. Thus we
conclude that in the absence of a specific
immune response (which C. parvum could
conceivably enhance) there will be no
effect of C. parvurn on micrometastases
which have already become extravascular.
These data are essentially in agreement
with the findings of Bomford & Olivotto
(1974) on the influence of timing on the
effect of C. parvum on ltunig-nodule forma-
tion after i.v. injection of tumour cells.
The conclusions are also consistent with
the work of Sadler & Castro (1976) who
observed a reduction in spontaneous
metastases from the Lewis lung carcinoma
only when C. parvurn was given 3 to 4 days
before amputation of the primary tumour.
Hewitt & Blake (1978) have also reported
no influence of C. parvum inoculation on
spontaneous metastases from two non-
immunogenic tumours. Our data suggest
that C. parvum will only be effective
against spontaneous metastases if given
before seeding tumour cells in the lungs.
Since Hewitt & Blake (1978) only tested
C. parvum 4 days before surgical removal
ofthe primary tumours, it is likely that by
this time micrometastases were already
developing in the mice and therefore
beyond the reach of C. parvum treatment.
Thus these results, together with those of
Sadler & Castro (1976) and Hewitt &
Blake (1978) demonstrate that for non-
immunogenic tumours C. parvum will only
be effective in preventing or reducing
metastatic spread which occurs after the
C. parvurn treatment.
These investigations were supported by Public
Healthl Service Research Grants CA-15201 andl
CA- 10372 from the National Cancer Instituite,
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